AD-116
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AD-116, covering 2025-10-03 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects [Phase 1]